clinical trials

TG Therapeutics, Inc. NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced…

Getting your annual flu shot may come with a significant side benefit: helping to protect you from dementia.…

In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize…

Retatrutide’s Triple Action Targets Metabolism Eli Lilly’s retatrutide drug is making waves in the metabolic health field. It…

Fresh funding backs the first human trial of a therapy designed to make older, damaged cells act younger…

The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…

One of the country’s first nurses dedicated to dementia research has been appointed in Sheffield to help build…

Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…

Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…

WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…

Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways stock soars after…

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting